Joseph Stokes, NP
Gerontology · Chicago, ILNPI 1336667955
Payments from drug & device makers
Across 657 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$5K
- Gilead$2K
- AbbVie$2K
- Merck$1K
- Novo Nordisk$957
- Napo Pharmaceuticals Inc$736
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$780%
- Food & beverage$15,67699%
- Education$1381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 155 | $5,220 |
| Gilead | 88 | $2,209 |
| AbbVie | 81 | $1,616 |
| Merck | 35 | $1,003 |
| Novo Nordisk | 56 | $957 |
| Napo Pharmaceuticals Inc | 52 | $736 |
| Axsome Therapeutics, Inc. | 20 | $512 |
| Amgen | 23 | $493 |
| Johnson & Johnson(2 entities) | 21 | $490 |
| EMD Serono, Inc. | 23 | $458 |
| Theratechnologies Inc. | 14 | $432 |
| Lilly USA, LLC | 17 | $351 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| Novartis | 8 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $135 |
| Exact Sciences | 4 | $91 |
| AstraZeneca | 4 | $91 |
| Pfizer | 4 | $80 |
| Antares Pharma, Inc. | 5 | $75 |
| Lundbeck LLC | 4 | $70 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Abbott | 3 | $59 |
| GSK | 3 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Halozyme Inc | 2 | $32 |
| Janssen Products, LP | 1 | $31 |
| Ardelyx, Inc. | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Corium, LLC | 1 | $21 |
| Corcept Therapeutics | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,892 in reported general payments places this provider in the 95th percentile of 180 gerontology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SerostimSomatropin | 49 | $1,121,653 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 90 | $392,159 |
| Humira(Cf) PenAdalimumab | 16 | $243,770 |
| Egrifta SvTesamorelin Acetate | 26 | $192,940 |
| CabenuvaCabotegravir/Rilpivirine | 27 | $188,001 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 25 | $90,702 |
| TivicayDolutegravir Sodium | 31 | $76,265 |
| IsentressRaltegravir Potassium | 31 | $72,976 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 13 | $71,122 |
| JulucaDolutegravir/Rilpivirine | 18 | $70,857 |
| DescovyEmtricitabine/Tenofov Alafenam | 29 | $69,470 |
| DovatoDolutegravir Sodium/Lamivudine | 20 | $69,276 |
| PrezcobixDarunavir/Cobicistat | 17 | $67,556 |
| OzempicSemaglutide | 63 | $61,942 |
| MounjaroTirzepatide | 33 | $34,850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| EMD Serono, Inc.Serostim | $458 | $1,121,65349 claims |
| GileadBiktarvy, Descovy | $2,209 | $461,630119 claims |
| Viiv Healthcare CompanyCabenuva, Tivicay, Juluca, Dovato | $5,220 | $404,39896 claims |
| Theratechnologies Inc.Egrifta Sv | $432 | $192,94026 claims |
| MerckIsentress, Pifeltro, Januvia, Belsomra | $1,003 | $129,27574 claims |
| Johnson & JohnsonPrezcobix, Xarelto | $490 | $74,91828 claims |
| Janssen Products, LPSymtuza | $31 | $71,12213 claims |
| Novo NordiskOzempic | $957 | $61,94263 claims |
| Lilly USA, LLCMounjaro | $351 | $34,85033 claims |
| Napo Pharmaceuticals IncMytesi | $736 | $29,02912 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $135 | $11,89314 claims |
| Antares Pharma, Inc.Xyosted | $75 | $9,90316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 180 gerontology providers in Illinois.
Other gerontology in Chicago
- Nestor Dante VeranoChicago$3K
- Laura WilliamsonChicago$3K
- Suchi LawrenceChicago$2K
- Josue NunezChicago$1K
- Reena ModiChicago$913
- Joanne MillerChicago$909
- Angela SchildgenChicago$792
- Atefeh DjavidChicago$684
- Tammy DobbinChicago$666
- Miriam CorreaChicago$468
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.